Latest News about JNJ
Recent news which mentions JNJ
Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
July 02, 2024
From Benzinga
From Benzinga
5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In First Half 2024
July 01, 2024
From Benzinga
From Motley Fool
3 Retirement All-Stars for Steady Growth and Income
July 01, 2024
From InvestorPlace
From InvestorPlace
Assessing Johnson & Johnson's Performance Against Competitors In Pharmaceuticals Industry
July 01, 2024
From Benzinga
From Benzinga
3 Magnificent Stocks Retirees Can Buy and Hold Forever
July 01, 2024
From Motley Fool
From InvestorPlace
From InvestorPlace
From Motley Fool
4 Cheap Stocks to Buy in July
June 29, 2024
From Motley Fool
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
June 28, 2024
From Benzinga
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
June 27, 2024
From Benzinga
2 Incredible Dividend Growth Stocks to Buy Right Now
June 27, 2024
From Motley Fool
The 3 Smartest Dow Stocks to Buy With $1000 Right Now
June 26, 2024
From InvestorPlace
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
June 26, 2024
From Benzinga
From Benzinga
From Motley Fool
2 Top Stocks to Buy Now for Years of Passive Income
June 22, 2024
From Motley Fool
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
From Benzinga
From Benzinga
From Benzinga
3 Healthcare Stocks to Buy Now: June 2024
June 20, 2024
From InvestorPlace
From InvestorPlace
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.